Skip to main content
OpenTrials

Clinical trial condition

Blood Coagulation Disorders, Inherited

Explore clinical trials studying Blood Coagulation Disorders, Inherited. Study availability and eligibility vary by location and protocol.

861 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Blood Coagulation Disorders, Inherited trial results

Recruiting

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

NCT06716814

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +16 more
Locations
  • Sobi Investigational Site Plovdiv, Bulgaria
  • Sobi Investigational Site Sofia, Bulgaria
  • Sobi Investigational Site Brest, France
  • Sobi Investigational Site Bron, France
View all 21 locations
View Trial Details
Recruiting

An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency

NCT07644832

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Xiangya Hospital of Central South University Changsha, China
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, China
  • Jinan Central Hospital Jinan, China
  • The First Hospital of Lanzhou University Lanzhou, China
View Trial Details
Recruiting

A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease

NCT07640893

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations
  • Xiangya Hospital of Central South University Changsha, China
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, China
  • Jinan Central Hospital Jinan, China
  • The First Affiliated Hospital of Guangxi Medical University Nanning, China
View Trial Details
Recruiting

A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.

NCT06703606

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Orthopaedic Institute for Children/Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States
  • Brody School of Medicine at East Carolina University Greenville, North Carolina, United States
  • ECU Health Medical Center Greenville, North Carolina, United States
  • Nirmal Hospital Pvt Ltd. Surat, Gujarat, India
View Trial Details
Recruiting

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

NCT05568719

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • The Regents of the University of California||UC Davis Health Rancho Cordova, California, United States
  • UC Davis Health Sacramento, California, United States
  • UC Davis Ambulatory Care Clinic Sacramento, California, United States
  • UC Davis Hemophilia Treatment Center Sacramento, California, United States
View all 23 locations
View Trial Details

Related conditions